ν•œλ… 둜고

ν•œλ… (002390) μ£Όκ°€ 및 μ’…λͺ© 정보

ν•œλ… μ‹€μ‹œκ°„ μ£Όκ°€

ν•œλ… ν˜„μž¬κ°€ 상세 정보
ν•­λͺ© κ°’
ν˜„μž¬κ°€ 11,900 원
λ³€λ™λŸ‰ β–Ό 10.00 원
변동λ₯  -0.08%
κ±°λž˜λŸ‰ 6,995
κ±°λž˜λŒ€κΈˆ 83,049,470 원

ν•œλ… 일별 μ£Όκ°€

ν•œλ…μ˜ κ³Όκ±° 일별 μ£Όκ°€
λ‚ μ§œ μ‹œκ°€ κ³ κ°€ μ €κ°€ μ’…κ°€ κ±°λž˜λŸ‰ κ±°λž˜λŒ€κΈˆ
6/30/2025 11,620 11,690 11,580 11,670 9,851 114,567,850
7/1/2025 11,600 11,700 11,550 11,700 6,290 72,996,680
7/2/2025 11,700 11,860 11,650 11,820 8,358 98,359,670
7/3/2025 11,820 11,830 11,700 11,750 7,662 89,947,530
7/6/2025 11,660 11,740 11,580 11,700 3,356 39,110,550
7/7/2025 11,690 11,720 11,610 11,660 4,811 56,146,420
7/8/2025 11,680 11,770 11,630 11,750 5,267 61,789,220
7/9/2025 11,770 11,850 11,730 11,840 8,120 95,790,570
7/10/2025 11,850 11,850 11,680 11,790 7,187 84,552,050
7/13/2025 11,770 11,920 11,740 11,910 9,341 110,421,055

κ΄€λ ¨ ν…Œλ§ˆ

  • 의료기기 : λ©΄μ—­ κ²€μ‚¬μš© μž₯λΉ„ μ„Όν† , μž„μƒν™”ν•™κ²€μ‚¬μš© μž₯λΉ„ λΉ„μŠ€νƒ€, ν˜ˆλ‹ΉμΈ‘μ •κΈ° λ°”λ‘œμž° λ“±μ˜ 진단기기 및 μ‹œμ•½ 사업을 μ˜μœ„ν•˜κ³  있음
  • μŠ€ν…Œλ‘œμ΄λ“œ : 덱사메타손 μ„±λΆ„μ˜ λ±μ‚¬μ†Œλ‘ μ • 0.75mg을 제쑰
  • Aν˜•κ°„μ—Ό : μ„±μΈμš© Aν˜• κ°„μ—Ό 백신인 "아박심TM 160U"의 판맀 및 μœ ν†΅μ„ λ‹΄λ‹Ήν•˜κ³  있음
  • μ œμ•½ : 당뇨병, κ³ ν˜ˆμ••μΉ˜λ£Œμ œ μ€‘μ‹¬μ˜ μ²˜λ°©μ˜μ•½ν’ˆ μ „λ¬Έ 쀑견 μ œμ•½μ—…μ²΄

ν•œλ… νšŒμ‚¬ 정보

μ‹œμž₯ μ‹œκ°€μ΄μ•‘ κΈ°μ—…μˆœμœ„ μ£Όμ‹μˆ˜ 외ꡭ인 비쀑 μ‚°μ—…κ΅° μ„ΈλΆ€ μ‚°μ—…κ΅° 52μ£Ό 졜고 52μ£Ό μ΅œμ €
kospi 1,637μ–΅ 583μœ„ 13,763,533 1.63% ν—¬μŠ€μΌ€μ–΄ μ œμ•½/건강기λŠ₯μ‹ν’ˆ 18,170 10,500

ν•œλ… κΈ°μ—… κ°œμš”

ν•œλ…μ€ 1958λ…„ μ„€λ¦½λœ κΈ°μ—…μœΌλ‘œ μ˜μ•½ν’ˆ, μ œμ•½μ›λ£Œ μ œμ‘°Β·νŒλ§€μ—…μ„ μ˜μœ„ν•˜κ³  μžˆλ‹€. μ£Όμš” 쒅속기업은 Theravalues Corporation, ν•œλ…μΉΌλ‘œμŠ€λ©”λ””μΉΌ, μ΄λ…ΈνλΈŒ 등이 μžˆλ‹€. μ£Όμš” λ§€μΆœμ€ μ˜μ•½ν’ˆ μ œμ‘°Β·νŒλ§€μ—μ„œ λ°œμƒν•˜κ³  있으며, μ‹œμ•½ 및 의료기기, μš©μ—­ 맀좜이 λ’€λ₯Ό μž‡κ³  μžˆλ‹€. λ©΄μ—­ν•­μ•”μ œ μ—°κ΅¬Β·κ°œλ°œ, νƒ€μ œμ•½μ‚¬μ™€ 기술제휴, μŠ€νƒ€νŠΈμ—… νšŒμ‚¬ 발꡴ 및 투자λ₯Ό ν†΅ν•œ κΈ°μ—…μ„±μž₯ μ „λž΅μ„ μΆ”κ΅¬ν•˜κ³  μžˆλ‹€.

μ΅œμ‹  ν•œλ… κ΄€λ ¨ λ‰΄μŠ€

μ˜μ•½ν’ˆ 생산곡정에 μžμœ¨ν˜•κ³΅μž₯ 적용 첫 μ‚¬λ‘€ν•œλ…μ€ μ€‘μ†Œλ²€μ²˜κΈ°μ—…λΆ€ μ‚°ν•˜ μŠ€λ§ˆνŠΈμ œμ‘°ν˜μ‹ μΆ”μ§„λ‹¨κ³Ό β€˜2025λ…„ μžμœ¨ν˜•κ³΅μž₯ ꡬ좕 지원사업’ ν˜‘μ•½μ„ μ²΄κ²°ν–ˆλ‹€κ³  26일 λ°ν˜”λ‹€. 이 사업은 곡μž₯ ..

ν•œλ…μ΄ ν•œκ΅­ν™˜κ²½κ³΅λ‹¨κ³Ό 2025λ…„ 슀마트 μƒνƒœκ³΅μž₯ ꡬ좕 사업에 λŒ€ν•œ ν˜‘μ•½μ„ μ²΄κ²°ν–ˆλ‹€κ³  19일 λ°ν˜”λ‹€. 슀마트 μƒνƒœκ³΅μž₯ ꡬ좕 사업은 ν•œκ΅­ν™˜κ²½κ³΅λ‹¨μ΄ μ£Όκ΄€ν•˜κ³  있으며 μ˜¨μ‹€κ°€μŠ€Β·μ˜€μ—Όλ¬Όμ§ˆ 저감, μ—λ„ˆμ§€Β·μžμ› 효율 제고λ₯Ό μœ„ν•΄ μΉœν™˜κ²½ 곡μž₯ μ „ν™˜ 및 ꡬ좕을 μ§€μ›ν•˜λŠ” 정뢀사업이닀. 이번 사업을 톡해 ν•œλ…μ€ μ„ λ„μ μœΌλ‘œ 펼쳐였고 μžˆλŠ” μΉœν™˜κ²½ κ²½μ˜μ„ κ°•ν™”ν•˜κ²Œ 됐닀. ν•œλ…μ€ μΉœν™˜κ²½ 슀마트 곡μž₯을 ꡬ좕해 μ—λ„ˆμ§€ νš¨μœ¨μ„ 높이고 μ˜€μ—Όλ¬Όμ§ˆ

μ΄ˆμ—¬λ¦„ 햇살이 λΉ„μΉ˜λŠ” 4일, 좩뢁 μ²­μ£Όμ‹œ 좩뢁산업μž₯λ €κ΄€. ν•œλ…μ΄ 이날뢀터 8μΌκΉŒμ§€ μš΄μ˜ν•˜λŠ” μ²΄ν—˜ν˜• νŒμ—…μŠ€ν† μ–΄ β€˜μ† νŽΈν•œ μ—°...

좩뢁도청 μ „κ²½. 좩뢁도 제곡. 좩뢁도가 μ§€μ—­ μ œμ•½κΈ°μ—…μΈ ν•œλ…κ³Ό μ†μž‘κ³  μ§€μ—­ 상생 사업을 μΆ”μ§„ν•œλ‹€. μΆ©λΆλ„λŠ” ν•œλ…κ³Ό μ§€μ—­ 상생을 μœ„ν•œ μ—…λ¬΄ν˜‘μ•½μ„ ν–ˆλ‹€κ³  4일 λ°ν˜”λ‹€. 1954λ…„ μ„€λ¦½λœ ν•œλ…μ€ μŒμ„±μ— μ˜μ•½ν’ˆ 생산 곡μž₯을 운영 쀑이닀. μ΄κ³³μ—λŠ” 2λ§Œμ—¬ 점의 μ˜μ•½ μœ λ¬Όμ„ λ³΄μœ ν•œ ν•œλ…μ˜μ•½λ°•λ¬Όκ΄€λ„ μžˆλ‹€. 이 기업은 μŒμ„±κ³Ό ν˜‘μ—…ν•΄ μ§€μ—­ 기업체듀을 λ‘˜λŸ¬λ³΄λŠ” β€˜νŒ©ν† λ¦¬Β·Β·Β·

μ‘°κ·œμ„ κ²½μ˜κ΄€λ¦¬ 및 생산총괄 λŒ€ν‘œμ΄μ‚¬ 사μž₯(μ™Όμͺ½)κ³Ό μ΅œμ§€ν˜„ μ˜μ—…λ§ˆμΌ€νŒ… 총괄 λŒ€ν‘œμ΄μ‚¬ 사μž₯ λ“± 2μ„Έ κ³΅λ™κ²½μ˜ μ²΄μ œκ°€ 막이 였λ₯΄λ©° μ‚Όμ§„μ œμ•½μ΄ μ™ΈλΆ€μΈμž¬ μ˜μž…μ„ 톡해 μƒˆνŒμ§œκΈ°μ— λ‚˜μ„°λ‹€λŠ” μ‹œμ„ μ΄ λ‚˜μ˜¨λ‹€.[λΉ„μ¦ˆλ‹ˆμŠ€ν¬μŠ€νŠΈ] μ‚Όμ§„μ œμ•½μ΄ 2μ„Έ 경영 μ‹œμž‘λΆ€ν„° 적극적 μ™ΈλΆ€μˆ˜ν˜ˆμ„ 톡해 경쟁λ ₯을 ν™•λ³΄ν•˜κ³  μžˆλ‹€.2μ„Έ 경영이 λ³Έκ²©ν™”λ˜λ©΄μ„œ μ‹ μ•½κ°œλ°œκ³Ό ν•¨κ»˜ 신사업 좔진을 톡해 ν•΄μ™Έ μ§„μΆœμ„ 천λͺ…ν•œ 만큼 이λ₯Ό μœ„ν•œ μ€€λΉ„λ₯Ό ν•˜κ³  μžˆλŠ” κ²ƒμœΌλ‘œ ν’€μ΄λœλ‹€.1일 λΉ„μ¦ˆλ‹ˆμŠ€ν¬μŠ€νŠΈ 취재λ₯Ό μ’…ν•©ν•˜λ©΄ μ‚Όμ§„μ œμ•½μ˜ 경영 총괄 μž„μ›μ„ μ±„μš©ν•  λ‹Ήμ‹œ 경쟁이 μΉ˜μ—΄ν–ˆλ˜ κ²ƒμœΌλ‘œ νŒŒμ•…λλ‹€. μ‚Όμ§„μ œμ•½μ΄ μ€‘κ²¬μ œμ•½μ‚¬μ΄μ§€λ§Œ 연봉 λ“± 볡지 λ“±μ˜ ν˜œνƒμ΄ μ•Œλ €μ§€λ©΄μ„œ μ§€μ›μžλ“€μ΄ λͺ°λ¦° κ²ƒμœΌλ‘œ μ•Œλ €μ‘Œλ‹€.λˆˆμ— λ„λŠ” 점은 κ²½μ˜μ΄κ΄„μ§μ— μ™ΈλΆ€ 인물을 μ˜μž…ν–ˆλ‹€λŠ” 점이닀.μ• μ΄ˆ μ‚Όμ§„μ œμ•½μ€ 곡동 창업주듀이 이

ν•œλ… 맀좜 정보

λ‚ μ§œ λ§€μΆœμ•‘ λ§€μΆœμ•‘ μ¦κ°€μœ¨ μ˜μ—…μ΄μ΅ μ˜μ—…μ΄μ΅ μ¦κ°€μœ¨ 순이읡 순이읡 μ¦κ°€μœ¨
2024.4Q 507,358,329,302 -2.94% 538,506,984 -95.72% -52,665,955,894 -81.98%
2023.4Q 522,741,079,531 -3.87% 12,578,832,018 -55.86% -28,940,426,192 -373.13%
2022.4Q 543,759,140,000 5.05% 28,496,185,000 1.75% 10,595,833,000 222.18%
2021.4Q 517,641,080,000 2.79% 28,006,350,000 -1.30% 3,288,807,200 -87.81%

μˆœλ§€μˆ˜λŸ‰

개인: -2,542

κΈ°κ΄€: 1,772

외인: 705

λˆ„μ  μˆœλ§€μˆ˜λŸ‰

개인: -1,943

κΈ°κ΄€: 7,308

외인: -6,471

순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2025-07-15 -2,542 1,772 705
2025-07-14 -84 -19 103
2025-07-11 512 -60 -494
2025-07-10 -2,538 -11 2,547
2025-07-09 -2,355 -3 2,030
2025-07-08 1,440 -237 -1,223
2025-07-07 -820 28 792
2025-07-04 1,476 57 -1,533
2025-07-03 -3,395 32 3,838
2025-07-02 1,953 49 -2,002
2025-07-01 -2,628 576 2,052
2025-06-30 -1,094 58 725
2025-06-27 693 -5 -682
2025-06-26 796 22 -942
2025-06-25 539 2 -959
2025-06-24 -4,359 1,680 2,690
2025-06-23 3,261 -1,535 -1,938
2025-06-20 -376 900 -524
2025-06-19 899 5 -904
2025-06-18 6,511 -3,319 -3,302
2025-06-17 2,845 1,577 -4,250

λˆ„μ  순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2025-07-15 734 1,569 -3,271
2025-07-14 3,276 -203 -3,976
2025-07-11 3,360 -184 -4,079
2025-07-10 2,848 -124 -3,585
2025-07-09 5,386 -113 -6,132
2025-07-08 7,741 -110 -8,162
2025-07-07 6,301 127 -6,939
2025-07-04 7,121 99 -7,731
2025-07-03 5,645 42 -6,198
2025-07-02 9,040 10 -10,036
2025-07-01 7,087 -39 -8,034
2025-06-30 9,715 -615 -10,086
2025-06-27 10,809 -673 -10,811
2025-06-26 10,116 -668 -10,129
2025-06-25 9,320 -690 -9,187
2025-06-24 8,781 -692 -8,228
2025-06-23 13,140 -2,372 -10,918
2025-06-20 9,879 -837 -8,980
2025-06-19 10,255 -1,737 -8,456
2025-06-18 9,356 -1,742 -7,552
2025-06-17 2,845 1,577 -4,250

ν•œλ… μžμ‚° λΉ„μœ¨

μžμ‚°μ΄κ³„ λΆ€μ±„λΉ„μœ¨ μžλ³ΈλΉ„μœ¨
822,118,177,795 65.97% 34.03%

ν•œλ… 맀좜 ꡬ성

ꡬ성 μš”μ†Œ λΉ„μœ¨
케토톱ꡰ, ν…Œλ„¬λ¦¬μ•„κ΅°, μ•„λ§ˆλ¦΄κ΅°, ν›ΌμŠ€νƒˆκ΅°, νŠΈλ¦¬ν…Œμ΄μŠ€κ΅°, ν…Œλ² ν…κ΅°, 기타 [μ˜μ•½ν’ˆμ œμ‘°λ°μ—… - μ œν’ˆ] 41.43%
μšΈν† λ―Έλ¦¬μŠ€, μŠ€ν‹Έλ…ΉμŠ€, μžνŠΈλž„, νŠΈλ¦¬λ ™νƒˆ, ν† λΉ„μ• μ¦ˆ, μ†”λ¦¬λ¦¬μŠ€, 기타 [μ˜μ•½ν’ˆμ œμ‘°λ°μ—… - μƒν’ˆ] 34.51%
BEPβ…’μ™Έ [μ§„λ‹¨κΈ°κΈ°λ°μ‹œμ•½] 15.63%
μš©μ—­μˆ˜μˆ˜λ£Œμ™Έ [μš©μ—­] 5.7%
λ„€μ΄μ²˜μ…‹, λ ˆλ””ν [μ»¨μŠˆλ¨Έν—¬μŠ€] 1.95%
κ±΄λ¬Όμž„λŒ€ [기타] 0.79%

ν•œλ… 곡맀도 ν˜„ν™©

졜근 곡맀도 κ±°λž˜λŸ‰: 25 (0.2%)

졜근 곡맀도 μž”κ³ : 0 (0%)

곡맀도 κ±°λž˜λŸ‰

λ‚ μ§œ μ’…κ°€ κ³΅λ§€λ„λŸ‰ 곡맀도비쀑
2025-07-14 11,910 25 0.20%
2025-07-11 11,790 5 0.05%
2025-07-10 11,840 13 0.09%
2025-07-09 11,750 3 0.03%
2025-07-08 11,660 29 0.38%
2025-07-07 11,700 0 0.00%
2025-07-04 11,750 0 0.00%
2025-07-03 11,820 0 0.00%
2025-07-02 11,700 0 0.00%
2025-07-01 11,670 0 0.00%
2025-06-30 11,630 15 0.12%
2025-06-27 11,520 31 0.25%
2025-06-26 11,700 3 0.02%
2025-06-25 11,720 10 0.06%
2025-06-24 11,840 19 0.07%
2025-06-23 11,570 6,465 14.79%
2025-06-20 11,550 724 4.94%
2025-06-19 11,500 430 8.29%
2025-06-18 11,500 1,082 8.11%
2025-06-17 11,560 866 7.15%
2025-06-16 11,670 2,334 8.19%

곡맀도 μž”κ³ 

λ‚ μ§œ μ’…κ°€ 곡맀도 μž”κ³  곡맀도 비쀑
2025-07-11 11,790 0 0.00%
2025-07-10 11,840 0 0.00%
2025-07-09 11,750 0 0.00%
2025-07-08 11,660 0 0.00%
2025-07-07 11,700 0 0.00%
2025-07-04 11,750 0 0.00%
2025-07-03 11,820 0 0.00%
2025-07-02 11,700 0 0.00%
2025-07-01 11,670 0 0.00%
2025-06-30 11,630 0 0.00%
2025-06-27 11,520 0 0.00%
2025-06-26 11,700 0 0.00%
2025-06-25 11,720 0 0.00%
2025-06-24 11,840 0 0.00%
2025-06-23 11,570 0 0.00%
2025-06-20 11,550 0 0.00%
2025-06-19 11,500 0 0.00%
2025-06-18 11,500 0 0.00%
2025-06-17 11,560 0 0.00%
2025-06-16 11,670 0 0.00%
2025-06-13 11,670 0 0.00%

ν•œλ… μ—…μ’… λ‚΄ 비ꡐ

μ œμ•½/건강기λŠ₯μ‹ν’ˆ μ—…μ’…(141개) μ—°κ°„ κΈ°μ€€

ν•­λͺ© ν•œλ… μ—…μ’… 평균 μ—…μ’… λ‚΄ μˆœμœ„
μ‹œκ°€μ΄μ•‘ 1,622.721 13,595.59 75μœ„
PER(졜근4λΆ„κΈ°) -2.798 0.81 88μœ„
PBR 583.756 6.54 1μœ„
ROE(졜근4λΆ„κΈ°) -16.793 -3.4 118μœ„
λ°°λ‹Ήμˆ˜μ΅λ₯ (μ΅œκ·Όμ—°λ„) 2.545 1.82 16μœ„
μ˜μ—…μ΄μ΅λ₯ (μ΅œκ·Όμ—°λ„) 0.106 -7,838.77 87μœ„
순이읡λ₯ (μ΅œκ·Όμ—°λ„) -10.38 -8,460.51 105μœ„
λΆ€μ±„λΉ„μœ¨(μ΅œκ·Όμ—°λ„) 172.8 75.44 9μœ„
λ§€μΆœμ•‘(μ΅œκ·Όμ—°λ„) 5,073.583 3,597.29 29μœ„
μ˜μ—…μ΄μ΅(μ΅œκ·Όμ—°λ„) 5.385 254.03 82μœ„
λ‹ΉκΈ°μˆœμ΄μ΅(μ΅œκ·Όμ—°λ„) -526.66 155.42 136μœ„